Skip to main content
HYUNDAI BIOSCIENCE CO., LTD. logo

HYUNDAI BIOSCIENCE CO., LTD. — Investor Relations & Filings

Ticker · 048410 ISIN · KR7048410005 KO Professional, scientific and technical activities
Open in API
Filings indexed 288 across all filing types
Latest filing 2023-10-05 AGM Information
Country KR South Korea
Listing KO 048410

About HYUNDAI BIOSCIENCE CO., LTD.

http://www.hyundaibioscience.com/eindex…

HYUNDAI BIOSCIENCE CO., LTD. is a biotechnology company focused on developing innovative therapeutics using its proprietary drug delivery system (DDS) technology. The company's core science is based on organic-inorganic hybrid technologies designed to safely and effectively deliver active ingredients. Its main development pipeline includes CP-COV03, a broad-spectrum antiviral agent that enhances cellular autophagy to combat viral infections, and Polytaxel, an anticancer drug candidate developed with polymer transfer technologies to reduce toxicity. The company's primary focus is on creating novel treatments for viral diseases and cancer.

Recent filings

Filing Released Lang Actions
주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for Hyundai Bioscience, detailing the date, location, and agenda items (specifically director and auditor remuneration limits). This type of document, which provides information to shareholders regarding an upcoming meeting and the matters to be voted upon, is classified as a Proxy Solicitation & Information Statement.
2023-10-05 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for an upcoming Extraordinary General Meeting (EGM) to determine shareholder voting rights. It is a standard corporate disclosure filed with the KRX (Korea Exchange). Since it is a regulatory announcement that does not fit into specific categories like dividend notices or proxy statements, and serves as a general regulatory disclosure, it is classified as RNS.
2023-10-05 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Hyundai Bioscience Co., Ltd., covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-11 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital changes and equity-based compensation falls under the category of 'Share Issue/Capital Change' (SHA) within the provided classification schema.
2023-07-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Oh Sang-ki) of Hyundai Bioscience. This type of filing, which details personal share transactions (disposals) by a company director, is classified as a Director's Dealing report.
2023-07-04 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Hyundai Bioscience Co., Ltd. for the period of Q1 2023 (2023.01.01-2023.03.31). It contains detailed financial statements, management discussion and analysis, and corporate governance information, which is characteristic of a comprehensive interim financial report. It is not an announcement of a report (RPA) or a simple certification (RNS), but the full report itself. Q1 2023
2023-05-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.